Physicochemical characterization and in vitro permeation of an indirubin derivative.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  European Journal of Pharmaceutical Sciences

• Publication date

  2013-11-20

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejps.2013.08.021PMID 23994641
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Indirubin derivatives induce apoptosis of chronic myelogenous leukemia cells involving inhibition of Stat5 signaling

  2012cited by this paper
• Impact of FaSSIF on the solubility and dissolution-/permeation rate of a poorly water-soluble compound.

  2012cited by this paper
• In vitro models to evaluate the permeability of poorly soluble drug entities: challenges and perspectives.

  2012cited by this paper
• Indirubin derivatives modulate TGFβ/BMP signaling at different levels and trigger ubiquitin-mediated depletion of nonactivated R-Smads.

  2012cited by this paper
• The solubility-permeability interplay: mechanistic modeling and predictive application of the impact of micellar solubilization on intestinal permeation.

  2011cited by this paper
• Effect of the non-ionic surfactant Poloxamer 188 on passive permeability of poorly soluble drugs across Caco-2 cell monolayers.

  2011cited by this paper
• Mechanisms of membrane transport of poorly soluble drugs: role of micelles in oral absorption processes.

  2010cited by this paper
• In vitro evaluation of liposomes containing bio-enhancers for the oral delivery of macromolecules.

  2010cited by this paper
• Preparation and Bioavailability Assessment of SMEDDS Containing Valsartan

  2010cited by this paper
• Analytical tools for the physicochemical profiling of drug candidates to predict absorption/distribution

  2009cited by this paper
• In vitro-in vivo correlation in P-glycoprotein mediated transport in intestinal absorption.

  2009cited by this paper
• Inhibition of P-glycoprotein at the blood-brain barrier by phytochemicals derived from traditional Chinese medicine.

  2009cited by this paper
• Using measured pKa, LogP and solubility to investigate supersaturation and predict BCS class.

  2008cited by this paper
• Soluble 3',6-substituted indirubins with enhanced selectivity toward glycogen synthase kinase -3 alter circadian period.

  2008cited by this paper
• The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats.

  2007cited by this paper
• Impact of cremophor-EL and polysorbate-80 on digoxin permeability across rat jejunum: delineation of thermodynamic and transporter related events using the reciprocal permeability approach.

  2007cited by this paper
• Diversity of the intracellular mechanisms underlying the anti-tumor properties of indirubins

  2007cited by this paper
• Drug Solubility in Water and Dimethylsulfoxide

  2007cited by this paper
• Molecular Drug Properties: Measurement and Prediction

  2007cited by this paper
• Permeability assessment of poorly water-soluble compounds under solubilizing conditions: the reciprocal permeability approach.

  2006cited by this paper
• Indirubin-3'-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer.

  2006cited by this paper
• Selectivity and potency of cyclin-dependent kinase inhibitors

  2006cited by this paper
• P‐Glycoprotein and Surfactants: Effect on Intestinal Talinolol Absorption

  2005cited by this paper
• Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells

  2005cited by this paper
• pK a , Solubility, and Lipophilicity

  2004cited by this paper
• Binding of the potential antitumour agent indirubin-5-sulphonate at the inhibitor site of rabbit muscle glycogen phosphorylase b. Comparison with ligand binding to pCDK2-cyclin A complex.

  2004cited by this paper
• Microarray-based Detection of Multidrug Resistance in Human Tumor Cells by Expression Profiling of ATP-binding Cassette Transporter Genes

  2004cited by this paper
• Physicochemical profiling: overview of the screens.

  2004cited by this paper
• Indirubin-3'-oxime inhibits c-Jun NH2-terminal kinase: anti-apoptotic effect in cerebellar granule neurons.

  2004cited by this paper
• GSK-3-selective inhibitors derived from Tyrian purple indirubins.

  2003cited by this paper
• Absorption and Drug Development: Solubility, Permeability, and Charge State

  2003cited by this paper
• Indirubin and Meisoindigo in the Treatment of Chronic Myelogenous Leukemia in China

  2002cited by this paper
• Physicochemical profiling (solubility, permeability and charge state).

  2001cited by this paper
• Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells

  2001cited by this paper
• Indirubin and Indigo Are Potent Aryl Hydrocarbon Receptor Ligands Present in Human Urine*

  2001cited by this paper
• Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?

  2001cited by this paper
• Anti-mitotic properties of indirubin-3′-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest

  2001cited by this paper
• PH-metric log P 11. pKa determination of water-insoluble drugs in organic solvent-water mixtures.

  1999cited by this paper
• Managing the drug discovery/development interface

  1997cited by this paper
• pH-Metric log P. 3. Glass electrode calibration in methanol-water, applied to pKa determination of water-insoluble substances

  1993cited by this paper
• Chinese Drugs of Plant Origin: Chemistry, Pharmacology, and Use in Traditional and Modern Medicine

  1992cited by this paper
• Chinese Drugs of Plant Origin

  1992influential reference
• Structure cristalline de l'indirubine

  1961cited by this paper

• Synthetic progress and anti-leukemic research on indirubin analogues: a review since 2010

  2025cites this paper
• Anti-Influenza Activity of 6BIGOE: Improved Pharmacological Profile After Encapsulation in PLGA Nanoparticles

  2025cites this paper
• The Fundamental Role of Oxime and Oxime Ether Moieties in Improving the Physicochemical and Anticancer Properties of Structurally Diverse Scaffolds

  2023cites this paper
• Drug delivery of 6-bromoindirubin-3’-glycerol-oxime ether employing poly(d,l-lactide-co-glycolide)-based nanoencapsulation techniques with sustainable solvents

  2022cites this paper
• Anticancer potential of indirubins in medicinal chemistry: Biological activity, structural modification, and structure-activity relationship.

  2021cites this paper
• Preparation and properties of hollow fibre nanofiltration membrane with continuous coffee-ring structure

  2020cites this paper
• Deciphering the mechanism of Indirubin and its derivatives in the inhibition of Imatinib resistance using a “drug target prediction-gene microarray analysis-protein network construction” strategy

  2019cites this paper
• Development and Evaluation of ADME Models Using Proprietary and Opensource Data

  2018cites this paper
• Comparative study of ascorbic acid and derivatives with interest in anti-aging cosmetics

  2017cites this paper
• Glucose-dependent regulation of pregnane X receptor is modulated by AMP-activated protein kinase

  2017cites this paper
• Identification of a Water-Soluble Indirubin Derivative as Potent Inhibitor of Insulin-like Growth Factor 1 Receptor through Structural Modification of the Parent Natural Molecule.

  2017cites this paper
• Methylisoindigo and Its Bromo-Derivatives Are Selective Tyrosine Kinase Inhibitors, Repressing Cellular Stat3 Activity, and Target CD133+ Cancer Stem Cells in PDAC

  2017cites this paper
• Effects of the Indirubin Derivative E804 on Glioblastoma Associated Immunomodulation

  2016cites this paper
• Drug Discovery from Mother Nature

  2016cites this paper
• The Role of Indirubins in Inflammation and Associated Tumorigenesis.

  2016cites this paper
• The octanol/water distribution coefficients of ardipusilloside-I and its metabolites, and their permeation characteristics across Caco-2 cell monolayer

  2016cites this paper
• In vitro and in vivo evaluations of the performance of an indirubin derivative, formulated in four different self‐emulsifying drug delivery systems

  2014cites this paper
• New perspective on the dual functions of indirubins in cancer therapy and neuroprotection.

  2014cites this paper